Clinigen Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Clinigen Group generated cash of $45,200,000, which is less than the previous year. Cash used in financing activities reached the amount of -$38,900,000 last year. Net change in cash is therefore -$60,200,000.
Cash Flow
| 2010 | -938K | -2.38M | 1.57M |
|---|---|---|---|
| 2011 | 12.25M | -4.01M | -455K |
| 2012 | 3.98M | -4.36M | -4.46M |
| 2016 | 42.1M | -30.4M | -12.3M |
| 2018 | 47.6M | -123.2M | 84.4M |
| 2020 | 60.6M | -81.4M | 77.9M |
| 2021 | 45.2M | -60.5M | -38.9M |
CLIN.L Cash Flow Statement (2010 – 2020)
| 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 143.1M | 83.5M | 27.8M | 27.8M | 8.38M | 1.02M | 3.04M |
Operating activities | |||||||
Net income | 30.3M | 13.7M | 27.4M | 13.5M | 6.59M | 4.31M | 912K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 57.6M | 56.5M | 23.8M | 20.8M | 1.22M | 1.11M | 502K |
Stock-based compensation expense | 3.7M | 3.5M | 2.1M | 1.8M | 4.61M | 0 | 0 |
| Deferred income tax benefit | 3.7M | 3.5M | 2.1M | 1.8M | 4.61M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -15.2M | -8.6M | -1.4M | -2.1M | -1.89M | -840K | 95K |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 45.2M | 60.6M | 47.6M | 42.1M | 3.98M | 12.25M | -938K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -28.3M | -23M | -12.3M | -8M | -4.36M | -4.01M | -1.38M |
Acquisitions Net | -31.6M | -58.4M | -70.7M | -22.4M | 0 | 0 | -1M |
Cash generated by investing activities | -60.5M | -81.4M | -123.2M | -30.4M | -4.36M | -4.01M | -2.38M |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 100K | 300K | 0 | 0 | 0 |
Payments for dividends | -10.1M | -9.2M | -6.3M | -4.1M | -781K | 0 | -1.1M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -30.9M | 0 | 0 | 0 | -3.68M | -455K | 0 |
Cash used in financing activities | -38.9M | 77.9M | 84.4M | -12.3M | -4.46M | -455K | 1.57M |
Net Change In Cash | -60.2M | 59.6M | 8.5M | 0 | -4.81M | 7.80M | -1.74M |
Cash at end of period | 82.9M | 143.1M | 36.3M | 27.8M | 3.57M | 8.83M | 1.3M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |